Sentinel System Bridge Contract

The Sentinel System Bridge Contract is a firm-fixed-price, sole-source award granted to Harvard Pilgrim Health Care Inc. to maintain the congressionally mandated Sentinel System. This bridge contract is necessary to ensure the continuity of critical drug safety monitoring and real-world evidence analysis while the Sentinel 3.0 contract award is delayed until FY2026. The total estimated value of the contract is $23,569,683.00, covering a base period from March 29, 2026, through September 28, 2026, with two subsequent six-month option periods extending the performance through September 28, 2027. Performance will take place in Canton, Massachusetts, under the oversight of the FDA Office of Acquisition and Grant Services. The scope of work requires the contractor to provide personnel, facilities, and administrative support for the ARIA system, regulatory support, and Real World Evidence capabilities using linked claims and electronic health record data. Key deliverables include maintaining 16 simultaneous analytical queries and delivering 152 principal programming hours while ensuring FISMA compliance for cybersecurity. The award was made without competition under FAR 6.103-1, justified by the contractor's unique qualifications, 15 years of institutional knowledge, and the critical need to prevent mission disruption. Government inspection and acceptance are managed by the FDA, specifically through the Contracting Officer's Representative.